Re-vaccination following Autologous Hematopoietic Stem Cell Transplantation is Safe and Effective in Patients with Multiple Myeloma Receiving Lenalidomide Maintenance

Guidelines recommend vaccination starting 12 months after autologous hematopoietic stem cell transplant (aHCT), but there is varying practice for patients on maintenance therapy, with some centers not immunizing at all. Due to decreased vaccine rates among the general population causing loss of herd...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Biol Blood Marrow Transplant
Main Authors: Palazzo, Meighan, Shah, Gunjan L., Copelan, Olivia, Seier, Kenneth, Devlin, Sean M., Maloy, Molly, Kenny, Sheila, Hassoun, Hani, Korde, Neha S., Lendvai, Nikoletta, Lesokhin, Alexander M., Mailankody, Sham, Chung, David J., Koehne, Guenther, Landgren, C. Ola, Landau, Heather, Giralt, Sergio A., Perales, Miguel-Angel
Formato: Artigo
Idioma:Inglês
Publicado em: 2017
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6673673/
https://ncbi.nlm.nih.gov/pubmed/29288818
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2017.12.795
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados